What are the key factors in research and development activities for a biotechnological company like Hemera?

The research and development team at HEMERA achieves great results in record time through intense teamwork and a shared passion for new discoveries. To reach the highest quality standards, it is necessary to work with rigor and perseverance and to tackle problems creatively. The combination of these factors has been fundamental in developing the new cellular therapy REMaST for the treatment of spinal cord injuries.

What are Hemera’s main research and development lines?

Hemera develops new cellular therapies for tissue regeneration, particularly focusing on nervous tissue, useful for treating conditions such as spinal cord injury.

What are the challenges and opportunities of research in regenerative medicine?

One of the biggest challenges in this field is regenerating nervous tissue because it cannot repair itself when damaged. Currently, there are no drugs available to repair brain and spinal cord injuries. HEMERA’s research opens a new opportunity to overcome this significant challenge.

What recent advancements in technology and science have had a significant impact on the therapy developed by HEMERA?

The HEMERA team has utilized technologies called “omics” combined with bioinformatic processing for their research. These new technologies allow us to obtain and process a vast amount of data on gene expression, proteins, and metabolism, describing the composition and function of individual cells. For example, through transcriptomics and proteomics, we can describe the specific characteristics of REMAST developed by HEMERA and the mechanisms of their functioning. These advanced insights enable us to develop a true technological platform for the development of different types of REMaST cells specific to treating various pathological conditions.